Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Profit After Tax (2017 - 2025)

Historic Profit After Tax for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$2.3 million.

  • Catheter Precision's Profit After Tax rose 4310.68% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.5 million, marking a year-over-year decrease of 4956.35%. This contributed to the annual value of -$16.6 million for FY2024, which is 7641.7% up from last year.
  • Latest data reveals that Catheter Precision reported Profit After Tax of -$2.3 million as of Q3 2025, which was up 4310.68% from -$5.5 million recorded in Q2 2025.
  • Catheter Precision's Profit After Tax's 5-year high stood at -$669000.0 during Q4 2023, with a 5-year trough of -$66.4 million in Q1 2023.
  • Its 5-year average for Profit After Tax is -$8.1 million, with a median of -$5.2 million in 2021.
  • In the last 5 years, Catheter Precision's Profit After Tax crashed by 110837.12% in 2023 and then skyrocketed by 9597.14% in 2024.
  • Catheter Precision's Profit After Tax (Quarter) stood at -$8.3 million in 2021, then grew by 1.54% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then plummeted by 741.26% to -$5.6 million in 2024, then skyrocketed by 58.35% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q3 2025, -$5.5 million for Q2 2025, and -$4.0 million during Q1 2025.